Overview

Safety and Pharmacokinetic Effects of Oseltamivir Alone or in Combination With Amantadine

Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
This study is designed to assess the safety and pharmacokinetic effects of oseltamivir administration alone or in combination with amantadine in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Novartis
Collaborator:
Hoffmann-La Roche
Treatments:
Amantadine
Oseltamivir